Incidence, Clinical Features, and Outcomes of Late-onset Neutropenia from Rituximab for Autoimmune Disease

OBJECTIVE: Late-onset neutropenia (LON) is an underrecognized complication of rituximab. Our objective is to describe its incidence, risk factors, clinical features, management, and recurrence. METHODS: We conducted a single-center retrospective cohort study of 738 adult patients with autoimmune dis...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Arthritis Rheumatol
Main Authors:	Zonozi, Reza, Wallace, Zachary S., Laliberte, Karen, Huizenga, Noah R., Rosenthal, Jillian M., Rhee, Eugene P., Cortazar, Frank B., Niles, John L.
Format:	Artigo
Sprog:	Inglês
Udgivet:	2020
Fag:	Article
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7902364/ https://ncbi.nlm.nih.gov/pubmed/32892495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41501
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Incidence, Clinical Features, and Outcomes of Late-onset Neutropenia from Rituximab for Autoimmune Disease

Lignende værker